The Homeopathic Medicinal Products Working Group (HMPWG) is a working group dedicated to homeopathic medicinal products for human and veterinary use. The aim of the HMPWG is to create a forum for exchange of regulatory and scientific expertise regarding the assessment of the quality, safety and homeopathic use of homeopathic medicinal products for human and veterinary use in the Member States; Harmonized guidance documents are published on the HMA website, for example on quality of homeopathic products, a list of First Safe Dilutions, and on proved homeopathic use. In all issues, more harmonization between Member States is the main objective.
The HMPWG is composed of representatives from the National Competent Authorities (NCAs) and veterinarian representatives. Representatives of the European Commission (EC) and European Medicines Agency (EMA) can attend all meetings of the HMPWG, as well as the European Pharmacopoeia.
25 June 2017 until 27 June 2017
Click here to view documents